David-Alexandre Gros

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ELDN

Current role

Board Member, CEO

9 calls Latest call 2023-05-11

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Eledon Pharmaceuticals, Inc. (ELDN)	Chief Executive Officer	$613,196	—	$268,660	$1,963,080	$349,522	$21,690	$3,216,148
2024	Eledon Pharmaceuticals, Inc. (ELDN)	Chief Executive Officer	$582,269	—	—	$4,577,034	$464,277	$21,390	$5,644,970
2023	Eledon Pharmaceuticals, Inc. (ELDN)	Chief Executive Officer	$559,478	—	—	$1,686,802	$286,383	$20,490	$2,553,153
2022	Eledon Pharmaceuticals, Inc. (ELDN)	Chief Executive Officer	$532,503	—	—	$310,538	$256,702	$18,750	$1,118,493
2021	Eledon Pharmaceuticals, Inc. (ELDN)	Chief Executive Officer	$503,654	—	—	—	$242,400	$1,450	$747,504
2020	Eledon Pharmaceuticals, Inc. (ELDN)	Chief Executive Officer	$150,000	—	—	$7,176,879	—	$92,428	$7,419,307

Earnings-call appearances and filed executive appointments or departures, newest first.